| |
Broward County Pharmacy Association to present three resolutions to the House of Delegates at the FPA Convention
June 30 - July 4, 2010 in Marco Island
Resolution #1
Freedom of Choice and Standardized Reimbursement
Whereas, Prescription dugs account for nearly 15% of America's healthcare costs. Yet
while Congress has spent the last year debating healthcare reforms, discussion on
reforming pharmacy has been nonexistent.
Be it Resolved, that the FPA work to support and endorce H.R. 4199 sponsored
by Representive Butterfield Tagged in the House of Representatives as the
Pharmacy Bill.
Be it further resolved that, if the bill fails to pass, FPA will continue to address the
bills key points in our States legislative agenda.
Intent: To address main concerns facing Pharmacy today, H.R. 4199 reflects major needs
of pharmacy. Equal access for the patient to go to the pharmacy of their choice.
Establishes at the Federal level Pharmacists being recognized as Healthcare Providers.
Carries manufactures' rebates directly back to the Federal Program not to the PBM.
Establishes a fairer pharmacy reimbursement structure.
Resolution #3
Physician Dispensing – Limiting Scope as Pertains to Controlled Substances
Be it Resolved that, The FPA work with the respective pharmacy and medical board’s to
limit the in office dispensing of controlled substances to a maximum of a 3 day supply.
This will allow the Patient to obtain a full dispensing by in a pharmacy if needed.
Intent: With the advent of Pain Management Clinics with Dispensaries, Patient safety and
control is lost by not having a Pharmacist to oversee the patient therapeutic management
within the guidelines of the FDA and Controlled Substance Abuse.
Resolution #2
Dispensing Provider
Whereas, Physican offices that utilize the ablity for their Physican to dispense is
not standardized.
Whereas, the Board of Pharmacy has no direct control on the Boards of Medicine,
and the interest of the public dispensing practices in accordance with Florida
Chapter 465, Florida Chapter 893 and DOH Rules 64B-16 need to be upheld.
Be it Resolved that: A Dispensing Physican Permit is to be under the direct
authority of the Board of Pharmacy. The duly licensed practitioner shall be
granted a Limited Dispensing Pharmacist permit which allows them to dispense
to their own patients. The requirements for a dispensing physician shall be the
same as for a dispensing pharmacist.
Be it Further Resolved, that a Policy and Proceedures manual be created outlining
adherence to all Statues and Rules.
Intent: Currently dispensing authority is monitored by respective medical boards
Broward County Pharmacist Assoc
Daniel P. Sweet RPh
Past President, Board Member
954-232-8202
Pharmacy Technician Registration Update
On-Line Florida Pharmacy Technician Registration will begin on October 1, 2009
Apply online OR re-apply now
Prior to January 1, 2010:
Effective January 1, 2010, any person who wishes to work as a pharmacy technician in the State of Florida must register with the Board of Pharmacy. To register with the Board of Pharmacy, an applicant must submit the following items:
- Pharmacy Technician Registration Application; and
- $105.00 Fee ($50.00 non-refundable application fee, $50.00 registration fee, $5.00 unlicensed application fee).
Any person who has completed a board approved technician-training program; or has completed 1500 hours of pharmacy technician work experience; or is a certified pharmacy technician may submit proof along with the initial application.
January 1, 2010 through December 31, 2010:
An applicant who has not met the education, work experience or certification requirements at the time of initial application may utilize January 1, 2010 through December 31, 2010 to complete one of the requirements.
- Must complete a board-approved pharmacy technician training program; or
- Must complete 1500 hours pharmacy technician work experience under the supervision of a licensed pharmacist; or
- Must be certified by an agency accredited by the National Commission for Certifying Agencies. For example, Pharmacy Technician Certification Board (PTCB), or Institute for the Certification of Pharmacy Technicians (ICPT).
A pharmacy technician registered prior to January 1, 2011, that fails to submit proof of completing one of the above requirements by December 31, 2010 will be required to re-register as a pharmacy technician, meeting the requirements below.
After January 1, 2011:
Effective January 1, 2011, any person who wishes to work as a pharmacy technician in the State of Florida must register with the Board of Pharmacy. To register with the Board of Pharmacy, an applicant must submit the following items:
- Pharmacy Technician Registration Application
- $105.00 Fee ($50.00 non-refundable application fee, $50.00 registration fee, $5.00 unlicensed application fee)
- Proof of completion of a board-approved pharmacy technician-training program.
Updated Negative Formulary
64B16-27.500 Negative Drug Formulary.
The negative drug formulary is composed of medicinal drugs which have been specifically determined by the Board of Pharmacy and the Board of Medicine to demonstrate clinically significant biological or therapeutic inequivalence and which, if substituted, could produce adverse clinical effects, or could otherwise pose a threat to the health and safety of patients receiving such prescription medications. Except where certain dosage forms are included on the negative drug formulary as a class, all medicinal drugs are listed by their official United States Pharmacopoeia Non-Proprietary (generic) name. The generic name of a drug shall be applicable to and include all brand-name equivalents of such drug for which a prescriber may write a prescription. Substitution by a dispensing pharmacist on a prescription written for any brand name equivalent of a generic named drug product listed on the negative formulary or for a drug within the class of certain dosage forms as listed, is strictly prohibited. In cases where the prescription is written for a drug listed on the negative drug formulary but a brand name equivalent is not specified by the prescriber, the drug dispensed must be one obtained from a manufacturer or distributor holding an approved new drug application or abbreviated new drug application issued by the Food and Drug Administration, United States Department of Health and Welfare permitting that manufacturer or distributor to market those medicinal drugs or when the former is non-applicable, those manufacturers or distributors supplying such medicinal drugs must show compliance with other applicable Federal Food and Drug Administration marketing requirements. The following are included on the negative drug formulary:
- Digitoxin.
- Conjugated Estrogen.
- Dicumarol.
- Chlorpromazine (Solid Oral Dosage Forms).
- Theophylline (Controlled Release).
- Levothyroxine Sodium.
- Pancrelipase (Oral Dosage Forms).
Specific Authority 465.005, 465.025(6) FS., Ch. 2001-146, Laws of Florida. Law Implemented 465.025(6) FS., Ch. 2001-146, Laws of Florida. History–New 12-14-76, Amended 3-17-77, 7-2-79, 4-9-81, 9-14-82, 9-26-84, Formerly 21S-5.01, Amended 3-30-89, 7-1-90, Formerly 21S-5.001, Amended 12-25-90, 10-1-92, Formerly 21S-27.500, Amended 2-21-94, Formerly 61F10-27.500, 59X-27.500, Amended 12-4-01.
Ammended Statute:
82 893.04, Florida Statutes, is amended to read:
83 Pharmacist and practitioner.— 893.04
84 (2)
85 Each written prescription prescribed by a practitioner (d)
86 in this state for a controlled substance listed in Schedule II,
87 Schedule III, or Schedule IV must include both a written and a
88 numerical notation of the quantity of the controlled substance
89 prescribed on the face of the prescription and a notation of the
90 date, with the abbreviated month written out on the face of the
91 prescription. A pharmacist may, upon verification by the
92 prescriber, document any information required by this paragraph.
93 If the prescriber is not available to verify a prescription, the
94 pharmacist may dispense the controlled substance but may insist
95 that the person to whom the controlled substance is dispensed
96 provide valid photographic identification. If a prescription
97 includes a numerical notation of the quantity of the controlled
98 substance or date, but does not include the quantity or date
99 written out in textual format, the pharmacist may dispense the
100 controlled substance without verification by the prescriber of
101 the quantity or date if the pharmacy previously dispensed
102 another prescription for the person to whom the prescription was
103 written.
104 This act shall take effect July 1, 2009. Section 6.
| |
Effective March 18, 2010
Rule 64B16-27.500, Florida Administrative Code (F.A.C.), is amended to remove levothyroxine sodium from Florida’s Negative Drug Formulary. Pursuant to Section 465.025(6)(b), Florida Statutes (F.S.), you are being notified of the deletion.
From March 18, 2010 forward, a pharmacist that receives a prescription for a brand name drug shall, unless requested otherwise by the purchaser, substitute a less expensive, generically equivalent drug product that is listed in the formulary of generic and brand name drug products as provided in Section 465.025(5), F.S., unless:
The prescriber writes the words “MEDICALLY NECESSARY,” in her or his own handwriting, on the face of a written prescription;
In the case of an oral prescription, the prescriber expressly indicates to the pharmacist that a brand name drug prescribed is medically necessary; or
In the case of a prescription that is electronically generated and transmitted, the prescriber makes an overt act when transmitting the prescription to indicate that the brand name drug prescribed is medically necessary.
If you have any questions concerning this notice, you may contact the Board of Pharmacy by telephone at (850) 245-4292 or by email.
| |
|
